Expected Outcome:
Proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- Patients benefit from decreased incidence of Adverse Drug Reactions (ADRs) caused by the administration of multiple medications (three or more medicinal products[1]) and enhanced health outcomes by ensuring safer and more effective use of medication.
- Healthcare professionals can adopt adverse drug reactions prevention and reduction strategies to integrate genetic and other biomarker information into clinical decision-making to optimise the use of medication, especially in situations of comorbidities.
- Healthcare systems benefit from cost savings thanks to reduced hospital admissions and other costs associated with ADRs related to the intake of multiple medicines.
- Clinical and regulatory guidelines and policies for medication management in case of multiple medications can be revised supported by robust evidence.
- Educational programs for healthcare providers and patients benefit from improved awareness and management of polypharmacy and ADRs.